These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24979997)

  • 1. [Treatment of vasculitis].
    Novak S
    Reumatizam; 2013; 60(2):47-54. PubMed ID: 24979997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab in the treatment of anti-neutrophil cytoplasm antibody-associated vasculitis.
    Jones RB
    Nephron Clin Pract; 2014; 128(3-4):243-9. PubMed ID: 25401382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L52. Vasculitis treatment: is it time to change the standard of care for ANCA-associated vasculitis?
    Hoffman GS
    Presse Med; 2013 Apr; 42(4 Pt 2):643-50. PubMed ID: 23474045
    [No Abstract]   [Full Text] [Related]  

  • 4. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis.
    Ntatsaki E; Carruthers D; Chakravarty K; D'Cruz D; Harper L; Jayne D; Luqmani R; Mills J; Mooney J; Venning M; Watts RA;
    Rheumatology (Oxford); 2014 Dec; 53(12):2306-9. PubMed ID: 24729399
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of rituximab in the treatment of ANCA-associated vasculitides (AAV).
    Daikeler T; Kistler AD; Martin PY; Vogt B; Huynh-Do U
    Swiss Med Wkly; 2015; 145():w14103. PubMed ID: 25658140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ANCA-associated vasculitis].
    Holle JU
    Internist (Berl); 2015 Jan; 56(1):41-50; quiz 51-2. PubMed ID: 25502657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological drugs in ANCA-associated vasculitis.
    Lutalo PM; D'Cruz DP
    Int Immunopharmacol; 2015 Aug; 27(2):209-12. PubMed ID: 25907243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of rituximab in the treatment of ANCA-associated systemic vasculitis].
    Roccatello D; Vangelista A; Pani A
    G Ital Nefrol; 2011; 28(5):474-88. PubMed ID: 22028261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L44. Management of relapses in vasculitis.
    Mouthon L
    Presse Med; 2013 Apr; 42(4 Pt 2):619-22. PubMed ID: 23477710
    [No Abstract]   [Full Text] [Related]  

  • 10. ANCA vasculitis: time for a change in treatment paradigm? Not yet.
    Ntatsaki E; Mooney J; Watts RA
    Rheumatology (Oxford); 2011 Jun; 50(6):1019-24. PubMed ID: 21292735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis.
    Rich EN; Brown KK
    Curr Opin Pulm Med; 2012 Sep; 18(5):447-54. PubMed ID: 22854508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the treatment of ANCA associated vasculitis.
    Smith RM
    Presse Med; 2015 Jun; 44(6 Pt 2):e241-9. PubMed ID: 26021670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rituximab for the treatment of ANCA associated vasculitis: the future today?].
    Alba MA; Flores-Suárez LF
    Reumatol Clin; 2011 Dec; 7 Suppl 3():S41-6. PubMed ID: 22115869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of primary vasculitides with biologic and novel small molecule medications.
    Serling-Boyd N; Wallace ZS
    Curr Opin Rheumatol; 2021 Jan; 33(1):8-14. PubMed ID: 33164993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of ANCA-associated vasculitis: new therapies and a look at old entities.
    Zand L; Specks U; Sethi S; Fervenza FC
    Adv Chronic Kidney Dis; 2014 Mar; 21(2):182-93. PubMed ID: 24602467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.
    Schönermarck U; Rau S; Fischereder M
    N Engl J Med; 2010 Nov; 363(21):2072; author reply 2073-4. PubMed ID: 21083401
    [No Abstract]   [Full Text] [Related]  

  • 17. Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.
    Hebert LA; Ardoin S; Shim RL
    N Engl J Med; 2010 Nov; 363(21):2072-3; author reply 2073-4. PubMed ID: 21083399
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of biologics in treatment of ANCA-associated vasculitis.
    Dharmapalaiah C; Watts RA
    Mod Rheumatol; 2012 Jun; 22(3):319-26. PubMed ID: 22038317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rituximab to treat ANCA-associated vasculitis].
    Guillevin L; Mahr A
    Rev Med Interne; 2011 Oct; 32(10):591-3. PubMed ID: 21872370
    [No Abstract]   [Full Text] [Related]  

  • 20. Rituximab in ANCA-associated disease.
    Falk RJ; Jennette JC
    N Engl J Med; 2010 Jul; 363(3):285-6. PubMed ID: 20647204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.